Azole-Induced Myositis after Combined Lung-Liver Transplantation

Lung transplant recipients experience a high rate of invasive pulmonary aspergillosis infections, for which voriconazole is the treatment of choice. We report a patient who developed voriconazole-induced myositis that relapsed after one dose of isavuconazole. Our patient was a 38-year-old man who re...

Full description

Saved in:
Bibliographic Details
Main Authors: Sofie Happaerts, Michiel Wieërs, Ward Vander Mijnsbrugge, Laurent Godinas, Dirk Van Raemdonck, Laurens J. Ceulemans, Robin Vos, Geert M. Verleden
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Transplantation
Online Access:http://dx.doi.org/10.1155/2022/7323755
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564911944761344
author Sofie Happaerts
Michiel Wieërs
Ward Vander Mijnsbrugge
Laurent Godinas
Dirk Van Raemdonck
Laurens J. Ceulemans
Robin Vos
Geert M. Verleden
author_facet Sofie Happaerts
Michiel Wieërs
Ward Vander Mijnsbrugge
Laurent Godinas
Dirk Van Raemdonck
Laurens J. Ceulemans
Robin Vos
Geert M. Verleden
author_sort Sofie Happaerts
collection DOAJ
description Lung transplant recipients experience a high rate of invasive pulmonary aspergillosis infections, for which voriconazole is the treatment of choice. We report a patient who developed voriconazole-induced myositis that relapsed after one dose of isavuconazole. Our patient was a 38-year-old man who received a single sequential lung transplantation and liver transplantation because of end-stage cystic fibrosis. He presented to our emergency room with acute pain in both forearms at 3 weeks after voriconazole was initiated for invasive pulmonary aspergillosis infection. Levels of voriconazole were normal during the course of therapy. After stopping voriconazole, the symptoms decreased but relapsed after one dose of isavuconazole. Other causes of muscle pain and inflammation were excluded. Magnetic resonance imaging of both arms showed muscle edema in both arms, including involvement of the fascia, consistent with myositis. There were no signs of necrosis. Isavuconazole was discontinued, and the corticosteroid dose was temporarily increased, with rapid resolution of all complaints. Our patient is the fourth reported case of voriconazole-induced myositis, and the first whose symptoms relapsed after initiating isavuconazole.
format Article
id doaj-art-bf781f25d7c34cc39fc97a292dc37167
institution Kabale University
issn 2090-6951
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Case Reports in Transplantation
spelling doaj-art-bf781f25d7c34cc39fc97a292dc371672025-02-03T01:09:52ZengWileyCase Reports in Transplantation2090-69512022-01-01202210.1155/2022/7323755Azole-Induced Myositis after Combined Lung-Liver TransplantationSofie Happaerts0Michiel Wieërs1Ward Vander Mijnsbrugge2Laurent Godinas3Dirk Van Raemdonck4Laurens J. Ceulemans5Robin Vos6Geert M. Verleden7Department of Respiratory Diseases and Lung TransplantationDepartment of Respiratory Diseases and Lung TransplantationDepartment of RadiologyDepartment of Respiratory Diseases and Lung TransplantationDepartment of Thoracic Surgery and Lung TransplantationDepartment of Thoracic Surgery and Lung TransplantationDepartment of Respiratory Diseases and Lung TransplantationDepartment of Respiratory Diseases and Lung TransplantationLung transplant recipients experience a high rate of invasive pulmonary aspergillosis infections, for which voriconazole is the treatment of choice. We report a patient who developed voriconazole-induced myositis that relapsed after one dose of isavuconazole. Our patient was a 38-year-old man who received a single sequential lung transplantation and liver transplantation because of end-stage cystic fibrosis. He presented to our emergency room with acute pain in both forearms at 3 weeks after voriconazole was initiated for invasive pulmonary aspergillosis infection. Levels of voriconazole were normal during the course of therapy. After stopping voriconazole, the symptoms decreased but relapsed after one dose of isavuconazole. Other causes of muscle pain and inflammation were excluded. Magnetic resonance imaging of both arms showed muscle edema in both arms, including involvement of the fascia, consistent with myositis. There were no signs of necrosis. Isavuconazole was discontinued, and the corticosteroid dose was temporarily increased, with rapid resolution of all complaints. Our patient is the fourth reported case of voriconazole-induced myositis, and the first whose symptoms relapsed after initiating isavuconazole.http://dx.doi.org/10.1155/2022/7323755
spellingShingle Sofie Happaerts
Michiel Wieërs
Ward Vander Mijnsbrugge
Laurent Godinas
Dirk Van Raemdonck
Laurens J. Ceulemans
Robin Vos
Geert M. Verleden
Azole-Induced Myositis after Combined Lung-Liver Transplantation
Case Reports in Transplantation
title Azole-Induced Myositis after Combined Lung-Liver Transplantation
title_full Azole-Induced Myositis after Combined Lung-Liver Transplantation
title_fullStr Azole-Induced Myositis after Combined Lung-Liver Transplantation
title_full_unstemmed Azole-Induced Myositis after Combined Lung-Liver Transplantation
title_short Azole-Induced Myositis after Combined Lung-Liver Transplantation
title_sort azole induced myositis after combined lung liver transplantation
url http://dx.doi.org/10.1155/2022/7323755
work_keys_str_mv AT sofiehappaerts azoleinducedmyositisaftercombinedlunglivertransplantation
AT michielwieers azoleinducedmyositisaftercombinedlunglivertransplantation
AT wardvandermijnsbrugge azoleinducedmyositisaftercombinedlunglivertransplantation
AT laurentgodinas azoleinducedmyositisaftercombinedlunglivertransplantation
AT dirkvanraemdonck azoleinducedmyositisaftercombinedlunglivertransplantation
AT laurensjceulemans azoleinducedmyositisaftercombinedlunglivertransplantation
AT robinvos azoleinducedmyositisaftercombinedlunglivertransplantation
AT geertmverleden azoleinducedmyositisaftercombinedlunglivertransplantation